Results 121 to 130 of about 81,875 (241)
Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea
Cellular and molecular mechanisms of obesity‐related obstructive sleep apnea (OSA). ADMA: asymmetric dimethyrarginine, NLRP3: nucleotide‐binding domain, leucine‐rich repeat family, Pyrin domain containing 3, TLR: toll‐like receptors, IL‐1β: interleukin‐1β, IL‐6: interleukin‐6; LPS: lipopolysacharide, ROS: reactive oxygen species, TNF‐α.
Anish Preshy +3 more
wiley +1 more source
Mitochondria and the Actin Cytoskeleton in Neurodegeneration
ABSTRACT Mitochondrial dysfunction and cytoskeletal disorganization are widely recognized hallmarks of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS).
Shivani Tuli +3 more
wiley +1 more source
Structural and Functional Imaging of Motor Outcomes in Twins With Perinatal Stroke: A Case Report
ABSTRACT Background Perinatal arterial ischemic stroke (AIS) affects 1 in 4000 live births. Dystonia, affecting ~20% of children following AIS, is characterized by involuntary muscle contractions and abnormal movements. Why some develop dystonia post AIS, while others do not, remains unclear.
Prisca Hsu +8 more
wiley +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
Correlation between blood biomarkers and post-stroke cognitive impairment. [PDF]
Liu X +6 more
europepmc +1 more source
Diagnosis and treatment of post-stroke cognitive impairment
The article is a review of literature on the etiology, pathogenesis, clinical manifestations of cognitive impairment in vascular pathology of the brain, as well as criteria for differential diagnosis of vascular and neurodegenerative cognitive impairment. Symptomatic and pathogenetic treatment of post-stroke cognitive impairment is discussed.
openaire +1 more source
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source
Iron metabolism dysregulation and post-stroke cognitive impairment: mechanisms and therapeutic perspectives. [PDF]
Guo ZM +5 more
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Prognostic Value of Elevated miR-502-3p in Patients With Post-Stroke Cognitive Impairment. [PDF]
Lin Y, Xu L, Zhang Y, Zou C.
europepmc +1 more source

